Kievmedpreparat JSC (UKEX:KMED) Shares Outstanding (EOP): 0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

UKEX:KMED Kievmedpreparat JSC UKEX:KMED
20 GF Score
Price ₴45.00
View Full Analysis

What is Kievmedpreparat JSC Shares Outstanding (EOP)?

Kievmedpreparat JSC UKEX:KMED 20 Shares Outstanding (EOP) is 0.00 Mil as of . 20. GuruFocus rates UKEX:KMED with a GF Score™ of 20/100.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Kievmedpreparat JSC's shares outstanding for the quarter that ended in . 20 was 0.00 Mil.

Kievmedpreparat JSC's quarterly shares outstanding stayed the same from . 20 (0.00 Mil) to . 20 (0.00 Mil).

Kievmedpreparat JSC's annual shares outstanding stayed the same from . 20 (0.00 Mil) to . 20 (0.00 Mil).


Kievmedpreparat JSC  (UKEX:KMED) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Kievmedpreparat JSC Shares Outstanding (EOP) Related Terms


Kievmedpreparat JSC Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Kievmedpreparat JSC's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kievmedpreparat JSC Shares Outstanding (EOP) Chart

Kievmedpreparat JSC Annual Data
Trend
Shares Outstanding (EOP)

Kievmedpreparat JSC Semi-Annual Data
Shares Outstanding (EOP)

UKEX:KMED vs : Shares Outstanding (EOP) Comparison

For the Drug Manufacturers - General subindustry, Kievmedpreparat JSC's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kievmedpreparat JSC Shares Outstanding (EOP) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kievmedpreparat JSC's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Kievmedpreparat JSC's Shares Outstanding (EOP) falls into.


UKEX:KMED
20GF Score
Kievmedpreparat JSC UKEX:KMED
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kievmedpreparat JSC Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 0.00 Mil mean?
Kievmedpreparat JSC (UKEX:KMED) has a Shares Outstanding (EOP) of 0.00 Mil as of . 20. The total shares a company has outstanding, at period-end. View historical data on Kievmedpreparat JSC and its competitors.
Is Kievmedpreparat JSC's Shares Outstanding (EOP) too high?
Kievmedpreparat JSC's current Shares Outstanding (EOP) is 0.00 Mil. Overall, Kievmedpreparat JSC has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Kievmedpreparat JSC's Shares Outstanding (EOP) compare to ?
Kievmedpreparat JSC's Shares Outstanding (EOP) of 0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Drug Manufacturers company?
A good Shares Outstanding (EOP) depends on the Drug Manufacturers industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Kievmedpreparat JSC and its competitors. Kievmedpreparat JSC's current Shares Outstanding (EOP) is 0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kievmedpreparat JSC stock overvalued right now?
Kievmedpreparat JSC (UKEX:KMED) has a current Shares Outstanding (EOP) of 0.00 Mil. The current Shares Outstanding (EOP) is 0.00 Mil. Kievmedpreparat JSC's overall GF Score™ is 20/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Kievmedpreparat JSC (UKEX:KMED), the current Shares Outstanding (EOP) is 0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kievmedpreparat JSC Business Description

Comparable Companies
Address 139 Saksaganskovo Street, Kyiv, UKR, 01032
Kievmedpreparat JSC is a pharmaceutical company that manufactures and markets both Rx and OTC medicines to Ukrainian and CIS markets.
20GF Score

Get the complete analysis for UKEX:KMED

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₴45.00
Price